Difficulty: Medium
Average Score: 77%
Simulated
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
Correct answer
D
Rationale
The correct answer is D: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs). Monitoring the WBC count is essential to evaluate the effectiveness of the treatment as an increase in WBC count indicates that the medication is working to boost the immune system.
A: Potassium level is not directly related to filgrastim therapy.
B: BUN (blood urea nitrogen) is not typically affected by filgrastim.
C: INR (International Normalized Ratio) is a measure of blood clotting and is not relevant to monitoring filgrastim therapy.
Therefore, the correct choice is D as it directly reflects the intended therapeutic effect of filgrastim.
A: Potassium level is not directly related to filgrastim therapy.
B: BUN (blood urea nitrogen) is not typically affected by filgrastim.
C: INR (International Normalized Ratio) is a measure of blood clotting and is not relevant to monitoring filgrastim therapy.
Therefore, the correct choice is D as it directly reflects the intended therapeutic effect of filgrastim.